The participation of CCP-aligned executives at a 2018 biopharmaceutical conference in China that Vivek Ramaswamy attended raises new questions about his presidential campaign’s commitment to ending U.S. dependence on Chinese pharmaceuticals.
In his effort to win the Republican presidential nomination, Ramaswamy has centered his foreign-policy strategy on combating the Chinese Communist Party, even dedicating an entire issues tab of his campaign website to declaring economic independence from Beijing. Ramaswamy’s prior business connections to CCP-aligned companies are extensive, but his appearance with executives affiliated with a controversial CCP program provides an uncomfortable contrast with his present-day platform.






Comments